Cancer cells coordinate a shift from glutaminolysis to de novo nucleotide biosynthesis via metabolic reprogramming coordinated by GLS1 and phosphoribosyl pyrophosphate amidotransferase (PPAT), the enzyme that initiates the rate-limiting step in de novo purine nucleotide biosynthesis [47]. This evidence concerns the gene PPAT and cancer.